Covered self-expandable metal stent deployment promises safe neoadjuvant chemoradiationtherapy in patients with borderline resectable pancreatic head cancer
Not Applicable
Recruiting
- Conditions
- Pancreatic cancer
- Registration Number
- JPRN-UMIN000009683
- Lead Sponsor
- Yokohama City University Endoscopic devision
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Not provided
Exclusion Criteria
Under the age of 19, non-Borderline resectable pancreatic head cancer based on NCCN guideline 2012.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Days to reintervention (DR), reintervention rate, the rate of R0 and complications were studied. Safe margin-negative resection (R0) surgery is defined as Ro surgery without reintervention during the NACRT period and no post operative complication.
- Secondary Outcome Measures
Name Time Method